Eva Tano
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antibiotic Resistance in Bacteria 9
-
- Antimicrobial Resistance in Staphylococcus 4
- Co-authors
- Dan I. Andersson (4 shared papers)Özden Baltekin (1 shared paper)Johan Elf (1 shared paper)Åsa Melhus (4 shared papers)Fredrik Huss (3 shared papers)Jan Sjölin (8 shared papers)Birgitta Lytsy (1 shared paper)Erik Torell (1 shared paper)
In The Last Decade
Eva Tano
24 papers receiving 778 citations
Peers
Comparison fields: 5 of 111
- Molecular Medicine 214
- Clinical Biochemistry 239
- Applied Microbiology and Biotechnology 44
- Endocrinology 62
- General Dentistry 16
Countries citing papers authored by Eva Tano
This map shows the geographic impact of Eva Tano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Tano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Tano more than expected).
Fields of papers citing papers by Eva Tano
This network shows the impact of papers produced by Eva Tano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Tano. The network helps show where Eva Tano may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Tano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 299 | |
| 2 | 2008 | 84 | |
| 3 | 2019 | 74 | |
| 4 | 2012 | 62 | |
| 5 | 2014 | 60 | |
| 6 | 2005 | 50 | |
| 7 | 2016 | 18 | |
| 8 | 2019 | 17 | |
| 9 | 2003 | 17 | |
| 10 | 2009 | 16 | |
| 11 | 2014 | 14 | |
| 12 | 2020 | 14 | |
| 13 | 2006 | 12 | |
| 14 | 2005 | 11 | |
| 15 | 2017 | 11 | |
| 16 | 2011 | 10 | |
| 17 | 2020 | 7 | |
| 18 | 2018 | 7 | |
| 19 | 2023 | 5 | |
| 20 | 2007 | 5 |
About Eva Tano
Eva Tano is a scholar working on Molecular Medicine, Infectious Diseases, Epidemiology, Immunology and Clinical Biochemistry, having authored 25 papers that have together received 800 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (9 papers), Immune Response and Inflammation (7 papers), Bacterial Identification and Susceptibility Testing (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Sepsis Diagnosis and Treatment (4 papers), Bacterial biofilms and quorum sensing (3 papers) and Infection Control and Ventilation (2 papers). The work is most often cited by research in Molecular Medicine (214 citations), Clinical Biochemistry (239 citations), Applied Microbiology and Biotechnology (44 citations), Endocrinology (62 citations) and General Dentistry (16 citations). Eva Tano has collaborated with scholars based in Sweden, Cambodia and Thailand. Frequent co-authors include Dan I. Andersson, Özden Baltekin, Johan Elf, Åsa Melhus, Fredrik Huss, Jan Sjölin, Birgitta Lytsy, Erik Torell, Linus Sandegren and Stefan Sütterlin. Their work appears in journals such as Apmis, PLoS ONE, Critical Care Medicine, Journal of Antimicrobial Chemotherapy and Journal of Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.